Depomed Inc (DEPO): Hedge Funds and Insiders Are Bullish, What Should You Do?
Depomed Inc (NASDAQ:DEPO) was in 13 hedge funds' portfolio at the end of the first quarter of 2013.
Sciclone Pharmaceuticals Inc (SCLN)
Market is closed
News
- First
- << Previous
- 11 - 14
SciClone Pharmaceuticals, Inc. (SCLN): Insiders Are Buying, Should You?
If you'd ask most market participants, hedge funds are assumed to be underperforming, old investment tools of yesteryear.
SciClone Pharmaceuticals, Inc. (SCLN): Insiders Aren't Crazy About It
According to most traders, hedge funds are perceived as underperforming, outdated financial tools of yesteryear.
Here is What Hedge Funds Think About SciClone Pharmaceuticals, Inc. (SCLN)
In the 21st century investor’s toolkit, there are a multitude of indicators investors can use to monitor publicly traded companies.
- First
- << Previous
- 11 - 14
Billionaire Hedge Funds
